ベンフォチアミンの世界市場レポート2020

• 英文タイトル：Global Benfotiamine Sales Market Report 2020

• レポートコード：20QY06-03685 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、ベンフォチアミンのグローバル市場について種類別（製薬用、食品用）、用途別（栄養補助食品、糖尿病性神経障害、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ベンフォチアミン市場の概要 ・世界の主要地域別ベンフォチアミン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のベンフォチアミン市場規模2015-2026：種類別（製薬用、食品用） ・世界のベンフォチアミン市場規模2015-2026：用途別（栄養補助食品、糖尿病性神経障害、その他） ・ベンフォチアミンの北米市場規模2015-2020 ・ベンフォチアミンのヨーロッパ市場規模2015-2020 ・ベンフォチアミンの中国市場規模2015-2020 ・ベンフォチアミンの日本市場規模2015-2020 ・ベンフォチアミンの東南アジア市場規模2015-2020 ・ベンフォチアミンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Klaire、、Hamari、、BioXera Pharma、、Kaival Chemicals、、Kimia Biosciences、、AOR、、Country Life、、Neurohacker Collective、、XY Mogen、、Prayosha Health Care、、Mascot、、Pharmaffiliates、、Hangzhou Eastbiopharm、、Basil Pharmaceuticals、、Ami Lifesciences、） ・ベンフォチアミンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ベンフォチアミンの市場動向・機会・課題 ・調査の結論

Benfotiamine is marketed as a dietary supplement in most of the developed world, and as a pharmaceutical drug in some countries for treating diabetic neuropathy

Market Analysis and Insights: Global Benfotiamine Market

The global Benfotiamine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.

Global Benfotiamine Scope and Market Size

The global Benfotiamine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Benfotiamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Benfotiamine market is segmented into

Pharma Grade

Food Grade

Segment by Application, the Benfotiamine market is segmented into

DietarySupplement

Diabetic Neuropathy

Others

The Benfotiamine market is analysed and market size information is provided by regions (countries). Segment by Application, the Benfotiamine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Benfotiamine Market Share Analysis

Benfotiamine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Benfotiamine business, the date to enter into the Benfotiamine market, Benfotiamine product introduction, recent developments, etc.

The major vendors covered:

Klaire

Hamari

BioXera Pharma

Kaival Chemicals

Kimia Biosciences

AOR

Country Life

Neurohacker Collective

XY Mogen

Prayosha Health Care

Mascot

Pharmaffiliates

Hangzhou Eastbiopharm

Basil Pharmaceuticals

Ami Lifesciences

レポート目次

---

Table of Contents

1 Benfotiamine Market Overview

1.1 Benfotiamine Product Scope

1.2 Benfotiamine Segment by Type

1.2.1 Global Benfotiamine Sales by Type (2020-2026)

1.2.2 Pharma Grade

1.2.3 Food Grade

1.3 Benfotiamine Segment by Application

1.3.1 Global Benfotiamine Sales Comparison by Application (2020-2026)

1.3.2 DietarySupplement

1.3.3 Diabetic Neuropathy

1.3.4 Others

1.4 Benfotiamine Market Estimates and Forecasts (2015-2026)

1.4.1 Global Benfotiamine Sales Growth Rate (2015-2026)

1.4.2 Global Benfotiamine Revenue and Growth Rate (2015-2026)

1.4.3 Global Benfotiamine Price Trends (2015-2026)

2 Benfotiamine Estimate and Forecast by Region

2.1 Global Benfotiamine Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Benfotiamine Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Benfotiamine Sales Market Share by Region (2015-2020)

2.2.2 Global Benfotiamine Revenue Market Share by Region (2015-2020)

2.3 Global Benfotiamine Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Benfotiamine Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Benfotiamine Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Benfotiamine Estimates and Projections (2015-2026)

2.4.2 Europe Benfotiamine Estimates and Projections (2015-2026)

2.4.3 China Benfotiamine Estimates and Projections (2015-2026)

2.4.4 Japan Benfotiamine Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Benfotiamine Estimates and Projections (2015-2026)

2.4.6 India Benfotiamine Estimates and Projections (2015-2026)

3 Global Benfotiamine Competition Landscape by Players

3.1 Global Top Benfotiamine Players by Sales (2015-2020)

3.2 Global Top Benfotiamine Players by Revenue (2015-2020)

3.3 Global Benfotiamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benfotiamine as of 2019)

3.4 Global Benfotiamine Average Price by Company (2015-2020)

3.5 Manufacturers Benfotiamine Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Benfotiamine Players (Opinion Leaders)

4 Global Benfotiamine Market Size by Type

4.1 Global Benfotiamine Historic Market Review by Type (2015-2020)

4.1.1 Global Benfotiamine Sales Market Share by Type (2015-2020)

4.1.2 Global Benfotiamine Revenue Market Share by Type (2015-2020)

4.1.3 Global Benfotiamine Price by Type (2014-2020)

4.2 Global Benfotiamine Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Benfotiamine Sales Forecast by Type (2021-2026)

4.2.2 Global Benfotiamine Revenue Forecast by Type (2021-2026)

4.2.3 Global Benfotiamine Price Forecast by Type (2021-2026)

5 Global Benfotiamine Market Size by Application

5.1 Global Benfotiamine Historic Market Review by Application (2015-2020)

5.1.1 Global Benfotiamine Sales Market Share by Application (2015-2020)

5.1.2 Global Benfotiamine Revenue Market Share by Application (2015-2020)

5.1.3 Global Benfotiamine Price by Application (2015-2020)

5.2 Global Benfotiamine Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Benfotiamine Sales Forecast by Application (2021-2026)

5.2.2 Global Benfotiamine Revenue Forecast by Application (2021-2026)

5.2.3 Global Benfotiamine Price Forecast by Application (2021-2026)

3 North America Benfotiamine Market Facts & Figures

3.2 North America Benfotiamine Sales Market Share by Company (2015-2020)

3.3 North America Benfotiamine Sales Market Share by Type (2015-2020)

3.4 North America Benfotiamine Sales Market Share by Application (2015-2020)

4 Europe Benfotiamine Market Facts & Figures

4.2 Europe Benfotiamine Sales Market Share by Company (2015-2020)

4.3 Europe Benfotiamine Sales Market Share by Type (2015-2020)

4.4 Europe Benfotiamine Sales Market Share by Application (2015-2020)

5 China Benfotiamine Market Facts & Figures

5.2 China Benfotiamine Sales Market Share by Company (2015-2020)

5.3 China Benfotiamine Sales Market Share by Type (2015-2020)

5.4 China Benfotiamine Sales Market Share by Application (2015-2020)

6 Japan Benfotiamine Market Facts & Figures

6.2 Japan Benfotiamine Sales Market Share by Company (2015-2020)

6.3 Japan Benfotiamine Sales Market Share by Type (2015-2020)

6.4 Japan Benfotiamine Sales Market Share by Application (2015-2020)

7 Southeast Asia Benfotiamine Market Facts & Figures

7.2 Southeast Asia Benfotiamine Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Benfotiamine Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Benfotiamine Sales Market Share by Application (2015-2020)

8 India Benfotiamine Market Facts & Figures

8.2 India Benfotiamine Sales Market Share by Company (2015-2020)

8.3 India Benfotiamine Sales Market Share by Type (2015-2020)

8.4 India Benfotiamine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Benfotiamine Business

12.1 Klaire

12.1.1 Klaire Benfotiamine Corporation Information

12.1.2 Klaire Benfotiamine Business Overview and Total Revenue

12.1.3 Klaire Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Klaire Benfotiamine Products Offered

12.1.5 Klaire Recent Development

12.2 Hamari

12.2.1 Hamari Benfotiamine Corporation Information

12.2.2 Hamari Benfotiamine Business Overview and Total Revenue

12.2.3 Hamari Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Hamari Benfotiamine Products Offered

12.2.5 Hamari Recent Development

12.3 BioXera Pharma

12.3.1 BioXera Pharma Benfotiamine Corporation Information

12.3.2 BioXera Pharma Benfotiamine Business Overview and Total Revenue

12.3.3 BioXera Pharma Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.3.4 BioXera Pharma Benfotiamine Products Offered

12.3.5 BioXera Pharma Recent Development

12.4 Kaival Chemicals

12.4.1 Kaival Chemicals Benfotiamine Corporation Information

12.4.2 Kaival Chemicals Benfotiamine Business Overview and Total Revenue

12.4.3 Kaival Chemicals Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Kaival Chemicals Benfotiamine Products Offered

12.4.5 Kaival Chemicals Recent Development

12.5 Kimia Biosciences

12.5.1 Kimia Biosciences Benfotiamine Corporation Information

12.5.2 Kimia Biosciences Benfotiamine Business Overview and Total Revenue

12.5.3 Kimia Biosciences Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Kimia Biosciences Benfotiamine Products Offered

12.5.5 Kimia Biosciences Recent Development

12.6 AOR

12.6.1 AOR Benfotiamine Corporation Information

12.6.2 AOR Benfotiamine Business Overview and Total Revenue

12.6.3 AOR Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.6.4 AOR Benfotiamine Products Offered

12.6.5 AOR Recent Development

12.7 Country Life

12.7.1 Country Life Benfotiamine Corporation Information

12.7.2 Country Life Benfotiamine Business Overview and Total Revenue

12.7.3 Country Life Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Country Life Benfotiamine Products Offered

12.7.5 Country Life Recent Development

12.8 Neurohacker Collective

12.8.1 Neurohacker Collective Benfotiamine Corporation Information

12.8.2 Neurohacker Collective Benfotiamine Business Overview and Total Revenue

12.8.3 Neurohacker Collective Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Neurohacker Collective Benfotiamine Products Offered

12.8.5 Neurohacker Collective Recent Development

12.9 XY Mogen

12.9.1 XY Mogen Benfotiamine Corporation Information

12.9.2 XY Mogen Benfotiamine Business Overview and Total Revenue

12.9.3 XY Mogen Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.9.4 XY Mogen Benfotiamine Products Offered

12.9.5 XY Mogen Recent Development

12.10 Prayosha Health Care

12.10.1 Prayosha Health Care Benfotiamine Corporation Information

12.10.2 Prayosha Health Care Benfotiamine Business Overview and Total Revenue

12.10.3 Prayosha Health Care Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Prayosha Health Care Benfotiamine Products Offered

12.10.5 Prayosha Health Care Recent Development

12.11 Mascot

12.11.1 Mascot Benfotiamine Corporation Information

12.11.2 Mascot Benfotiamine Business Overview and Total Revenue

12.11.3 Mascot Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Mascot Benfotiamine Products Offered

12.11.5 Mascot Recent Development

12.12 Pharmaffiliates

12.12.1 Pharmaffiliates Benfotiamine Corporation Information

12.12.2 Pharmaffiliates Benfotiamine Business Overview and Total Revenue

12.12.3 Pharmaffiliates Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Pharmaffiliates Benfotiamine Products Offered

12.12.5 Pharmaffiliates Recent Development

12.13 Hangzhou Eastbiopharm

12.13.1 Hangzhou Eastbiopharm Benfotiamine Corporation Information

12.13.2 Hangzhou Eastbiopharm Benfotiamine Business Overview and Total Revenue

12.13.3 Hangzhou Eastbiopharm Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.13.4 Hangzhou Eastbiopharm Benfotiamine Products Offered

12.13.5 Hangzhou Eastbiopharm Recent Development

12.14 Basil Pharmaceuticals

12.14.1 Basil Pharmaceuticals Benfotiamine Corporation Information

12.14.2 Basil Pharmaceuticals Benfotiamine Business Overview and Total Revenue

12.14.3 Basil Pharmaceuticals Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.14.4 Basil Pharmaceuticals Benfotiamine Products Offered

12.14.5 Basil Pharmaceuticals Recent Development

12.15 Ami Lifesciences

12.15.1 Ami Lifesciences Benfotiamine Corporation Information

12.15.2 Ami Lifesciences Benfotiamine Business Overview and Total Revenue

12.15.3 Ami Lifesciences Benfotiamine Sales, Revenue and Gross Margin (2015-2020)

12.15.4 Ami Lifesciences Benfotiamine Products Offered

12.15.5 Ami Lifesciences Recent Development

13 Benfotiamine Manufacturing Cost Analysis

13.1 Benfotiamine Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Benfotiamine

13.4 Benfotiamine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Benfotiamine Distributors List

14.3 Benfotiamine Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables



Table 1. Global Benfotiamine Sales (MT) Growth Rate by Type (2020-2026)

Table 2. Global Benfotiamine Sales (MT) Comparison by Application (2020-2026)

Table 3. Global Market Benfotiamine Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 4. Global Benfotiamine Sales (MT) by Region (2015-2020)

Table 5. Global Benfotiamine Sales Market Share by Region (2015-2020)

Table 6. Global Benfotiamine Revenue (US$ Million) Market Share by Region (2015-2020))

Table 7. Global Benfotiamine Revenue Share by Region (2015-2020)

Table 8. Global Benfotiamine Sales (MT) Forecast by Region (2021-2026)

Table 9. Global Benfotiamine Sales Market Share Forecast by Region (2021-2026)

Table 10. Global Benfotiamine Revenue (US$ Million) Forecast by Region (2021-2026)

Table 11. Global Benfotiamine Revenue Share Forecast by Region (2021-2026)

Table 12. Global Benfotiamine (MT) of Key Companies (2015-2020)

Table 13. Global Benfotiamine Sales Share by Company (2015-2020)

Table 14. Global Benfotiamine Revenue (US$ Million) by Company (2015-2020)

Table 15. Global Benfotiamine Revenue Share by Company (2015-2020)

Table 16. Global Benfotiamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Benfotiamine as of 2019)

Table 17. Global Benfotiamine Average Price (USD/MT) of Key Company (2015-2020)

Table 18. Manufacturers Benfotiamine Manufacturing Sites and Area Served

Table 19. Manufacturers Benfotiamine Product Type

Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 21. Main Points Interviewed from Key Benfotiamine Players

Table 22. Global Benfotiamine Sales (MT) by Type (2015-2020)

Table 23. Global Benfotiamine Sales Share by Type (2015-2020)

Table 24. Global Benfotiamine Revenue (US$ Million) Market Share by Type (2015-2020)

Table 25. Global Benfotiamine Price (MT) by Type (2015-2020)

Table 26. Global Benfotiamine Sales Share by Type (2021-2026)

Table 27. Global Benfotiamine Revenue (US$ Million) Market Share by Type (2021-2026)

Table 28. Global Benfotiamine Revenue Share by Type (2021-2026)

Table 29. Global Benfotiamine Price (MT) by Type (2021-2026)

Table 30. Global Benfotiamine Sales (MT) by Application (2015-2020)

Table 31. Global Benfotiamine Sales Share by Application (2015-2020)

Table 32. Global Benfotiamine Revenue (US$ Million) Market Share by Application (2015-2020)

Table 33. Global Benfotiamine Price (MT) by Application (2015-2020)

Table 34. Global Benfotiamine Sales (MT) by Application (2021-2026)

Table 35. Global Benfotiamine Sales Share by Application (2021-2026)

Table 36. Global Benfotiamine Revenue (US$ Million) Market Share by Application (2021-2026)

Table 37. Global Benfotiamine Revenue Share by Application (2021-2026)

Table 38. Global Benfotiamine Price (MT) by Application (2021-2026)

Table 39. United States Benfotiamine Sales (MT) by Company (2015-2020)

Table 40. United States Benfotiamine Sales Market Share by Company (2015-2020)

Table 41. United States Benfotiamine Sales (MT) by Type (2015-2020)

Table 42. United States Benfotiamine Sales Market Share by Type (2015-2020)

Table 43. United States Benfotiamine Sales (MT) by Application (2015-2020)

Table 44. United States Benfotiamine Sales Market Share by Application (2015-2020)

Table 45. Europe Benfotiamine Sales (MT) by Company (2015-2020)

Table 46. Europe Benfotiamine Sales Market Share by Company (2015-2020)

Table 47. Europe Benfotiamine Sales (MT) by Type (2015-2020)

Table 48. Europe Benfotiamine Sales Market Share by Type (2015-2020)

Table 49. Europe Benfotiamine Sales (MT) by Application (2015-2020)

Table 50. Europe Benfotiamine Sales Market Share by Type (2015-2020)

Table 51. China Benfotiamine Sales (MT) by Company (2015-2020)

Table 52. China Benfotiamine Sales Market Share by Company (2015-2020)

Table 53. China Benfotiamine Sales (MT) by Type (2015-2020)

Table 54. China Benfotiamine Sales Market Share by Type (2015-2020)

Table 55. China Benfotiamine Sales (MT) by Application (2015-2020)

Table 56. China Benfotiamine Sales Market Share by Application (2015-2020)

Table 57. Japan Benfotiamine Sales (MT) by Company (2015-2020)

Table 58. Japan Benfotiamine Sales Market Share by Company (2015-2020)

Table 59. Japan Benfotiamine Sales (MT) by Type (2015-2020)

Table 60. Japan Benfotiamine Sales Market Share by Type (2015-2020)

Table 61. Japan Benfotiamine Sales (MT) by Application (2015-2020)

Table 62. Japan Benfotiamine Sales Market Share by Application (2015-2020)

Table 63. Southeast Asia Benfotiamine Sales (MT) by Company (2015-2020)

Table 64. Southeast Asia Benfotiamine Sales Market Share by Company (2015-2020)

Table 65. Southeast Asia Benfotiamine Sales (MT) by Type (2015-2020)

Table 66. Southeast Asia Benfotiamine Sales Market Share by Type (2015-2020)

Table 67. Southeast Asia Benfotiamine Sales (MT) by Type (2015-2020)

Table 68. Southeast Asia Benfotiamine Sales Market Share by Application (2015-2020)

Table 69. India Benfotiamine Sales (MT) by Company (2015-2020)

Table 70. India Benfotiamine Sales Market Share by Company (2015-2020)

Table 71. India Benfotiamine Sales (MT) by Type (2015-2020)

Table 72. India Benfotiamine Sales Market Share by Type (2015-2020)

Table 73. India Benfotiamine Sales (MT) by Application (2015-2020)

Table 74. India Benfotiamine Sales Market Share by Application (2015-2020)

Table 75. Klaire Corporation Information

Table 76. Klaire Description and Business Overview

Table 77. Klaire Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 78. Klaire Benfotiamine Product

Table 79. Klaire Recent Development

Table 80. Hamari Corporation Information

Table 81. Hamari Description and Business Overview

Table 82. Hamari Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 83. Hamari Benfotiamine Product

Table 84. Hamari Recent Development

Table 85. BioXera Pharma Corporation Information

Table 86. BioXera Pharma Description and Business Overview

Table 87. BioXera Pharma Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 88. BioXera Pharma Benfotiamine Product

Table 89. BioXera Pharma Recent Development

Table 90. Kaival Chemicals Corporation Information

Table 91. Kaival Chemicals Description and Business Overview

Table 92. Kaival Chemicals Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 93. Kaival Chemicals Benfotiamine Product

Table 94. Kaival Chemicals Recent Development

Table 95. Kimia Biosciences Corporation Information

Table 96. Kimia Biosciences Description and Business Overview

Table 97. Kimia Biosciences Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 98. Kimia Biosciences Benfotiamine Product

Table 99. Kimia Biosciences Recent Development

Table 100. AOR Corporation Information

Table 101. AOR Description and Business Overview

Table 102. AOR Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 103. AOR Benfotiamine Product

Table 104. AOR Recent Development

Table 105. Country Life Corporation Information

Table 106. Country Life Description and Business Overview

Table 107. Country Life Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 108. Country Life Benfotiamine Product

Table 109. Country Life Recent Development

Table 110. Neurohacker Collective Corporation Information

Table 111. Neurohacker Collective Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 112. Neurohacker Collective Description and Business Overview

Table 113. Neurohacker Collective Benfotiamine Product

Table 114. Neurohacker Collective Recent Development

Table 115. XY Mogen Corporation Information

Table 116. XY Mogen Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 117. XY Mogen Description and Business Overview

Table 118. XY Mogen Benfotiamine Product

Table 119. XY Mogen Recent Development

Table 120. Prayosha Health Care Corporation Information

Table 121. Prayosha Health Care Description and Business Overview

Table 122. Prayosha Health Care Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 123. Prayosha Health Care Benfotiamine Product

Table 124. Prayosha Health Care Recent Development

Table 125. Mascot Corporation Information

Table 126. Mascot Description and Business Overview

Table 127. Mascot Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 128. Mascot Benfotiamine Product

Table 129. Mascot Recent Development

Table 130. Pharmaffiliates Corporation Information

Table 131. Pharmaffiliates Description and Business Overview

Table 132. Pharmaffiliates Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 133. Pharmaffiliates Benfotiamine Product

Table 134. Pharmaffiliates Recent Development

Table 135. Hangzhou Eastbiopharm Corporation Information

Table 136. Hangzhou Eastbiopharm Description and Business Overview

Table 137. Hangzhou Eastbiopharm Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 138. Hangzhou Eastbiopharm Benfotiamine Product

Table 139. Hangzhou Eastbiopharm Recent Development

Table 140. Basil Pharmaceuticals Corporation Information

Table 141. Basil Pharmaceuticals Description and Business Overview

Table 142. Basil Pharmaceuticals Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 143. Basil Pharmaceuticals Benfotiamine Product

Table 144. Basil Pharmaceuticals Recent Development

Table 145. Ami Lifesciences Corporation Information

Table 146. Ami Lifesciences Description and Business Overview

Table 147. Ami Lifesciences Benfotiamine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)

Table 148. Ami Lifesciences Benfotiamine Product

Table 149. Ami Lifesciences Recent Development

Table 150. Production Base and Market Concentration Rate of Raw Material

Table 151. Key Suppliers of Raw Materials

Table 152. Benfotiamine Distributors List

Table 153. Benfotiamine Customers List

Table 154. Market Key Trends

Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 156. Key Challenges

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Benfotiamine Product Picture

Figure 2. Global Benfotiamine Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Benfotiamine Market Share by Application in 2020 & 2026

Figure 6. DietarySupplement Examples

Figure 7. Diabetic Neuropathy Examples

Figure 8. Others Examples

Figure 9. Global Benfotiamine Sales (MT) Growth Rate (2015-2026)

Figure 10. Global Benfotiamine Revenue (US$ Million) Growth Rate (2015-2026)

Figure 11. Global Benfotiamine Price Trends Growth Rate (2015-2026) (USD/MT)

Figure 12. Global Benfotiamine Revenue Market Share by Region: 2015 VS 2020

Figure 13. Global Benfotiamine Revenue Market Share by Region: 2021 VS 2026

Figure 14. United States Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 15. United States Benfotiamine Sales (MT) Growth Rate (2015-2026)

Figure 16. Europe Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. Europe Benfotiamine Sales (Million USD) Growth Rate (2015-2026)

Figure 18. China Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. China Benfotiamine Sales (Million USD) and Growth Rate (2015-2026)

Figure 20. Japan Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. Japan Benfotiamine Sales (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Benfotiamine Sales (Million USD) Growth Rate (2015-2026)

Figure 24. India Benfotiamine Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. India Benfotiamine Sales (Million USD) Growth Rate (2015-2026)

Figure 26. Global 5 Largest Benfotiamine Players Market Share by Revenue in Benfotiamine 2015 & 2019

Figure 27. Benfotiamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 28. Global Benfotiamine Revenue Share by Type (2015-2020)

Figure 29. Global Benfotiamine Revenue Growth Rate by Type in 2015 & 2019

Figure 30. Global Benfotiamine Revenue Share by Application (2015-2020)

Figure 31. Global Benfotiamine Revenue Growth Rate by Application in 2015 & 2019

Figure 32. United States Benfotiamine Sales Market Share by Type in 2019

Figure 33. United States Benfotiamine Sales Market Share by Type in 2019

Figure 34. Europe Benfotiamine Sales Market Share by Company in 2019

Figure 35. Europe Benfotiamine Sales Market Share by Type in 2019

Figure 36. Europe Benfotiamine Sales Market Share by Application in 2019

Figure 37. China Benfotiamine Sales Market Share by Company in 2019

Figure 38. China Benfotiamine Sales Market Share by Type in 2019

Figure 39. China Benfotiamine Sales Market Share by Application in 2019

Figure 40. Japan Benfotiamine Sales Market Share by Company in 2019

Figure 41. Japan Benfotiamine Sales Market Share by Type in 2019

Figure 42. Japan Benfotiamine Sales Market Share by Application in 2019

Figure 43. Southeast Asia Benfotiamine Sales Market Share by Company in 2019

Figure 44. Southeast Asia Benfotiamine Sales Market Share by Type in 2019

Figure 45. Southeast Asia Benfotiamine Sales Market Share by Application in 2019

Figure 46. India Benfotiamine Sales Market Share by Company in 2019

Figure 47. India Benfotiamine Sales Market Share by Type in 2019

Figure 48. India Benfotiamine Sales Market Share by Application in 2019

Figure 49. Klaire Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Hamari Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. BioXera Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Kaival Chemicals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Kimia Biosciences Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. AOR Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Country Life Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Neurohacker Collective Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. XY Mogen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Prayosha Health Care Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Mascot Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Pharmaffiliates Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Hangzhou Eastbiopharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Basil Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 63. Ami Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018

Figure 64. Key Raw Materials Price Trend

Figure 65. Manufacturing Cost Structure of Benfotiamine

Figure 66. Manufacturing Process Analysis of Benfotiamine

Figure 67. Benfotiamine Industrial Chain Analysis

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

Figure 70. Porter's Five Forces Analysis

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

---